Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2010
06/17/2010US20100152200 Alphavirus inhibitors and uses thereof
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152190 Substituted Pyrrolidine-2-Carboxamides
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
06/17/2010US20100152183 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/17/2010US20100152125 Compositions And Methods For The Diagnosis, Treatment, And Prevention Of Amyotrophic Lateral Sclerosis And Related Neurological Diseases
06/17/2010US20100152112 Quinoline derivatives as p13 kinase inhibitors
06/17/2010US20100152047 Piperazine Compounds Whith a Herbicidal Action
06/17/2010US20100150863 Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
06/17/2010US20100148161 Compound for organic electroluminescent device and organic electroluminescent device
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2747279A1 3,4 - substituted piperidine derivatives as renin inhibitors
06/17/2010CA2747185A1 Compounds for treating cancer
06/17/2010CA2746357A1 P38 map kinase inhibitors
06/17/2010CA2746354A1 P38 map kinase inhibitors
06/17/2010CA2745969A1 4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of ccr2
06/17/2010CA2745870A1 A new process for preparing 4-[4-methyl-5-(c1-10alkylthio/c5-10aryl-c1-6alkylthio)-4h-1,2,4-triazol-3-yl]pyridines
06/17/2010CA2744124A1 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
06/16/2010EP2196465A1 (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010EP2195312A1 Pyridine derivatives useful as glucokinase activators
06/16/2010EP2195309A2 Polymorphs of esomeprazole salts
06/16/2010EP2195302A2 Insecticidal substituted azinyl derivatives
06/16/2010EP2195296A1 Quinoline derivatives as 5ht5a receptor antagonists
06/16/2010EP2195294A1 Novel preparation process
06/16/2010EP2195288A2 Small molecule bradykinin b1 receptor antagonists
06/16/2010EP2194985A1 Antimalarial compounds with flexible side-chains
06/16/2010EP2194983A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010EP2194982A1 Compounds which have activity at m1 receptor and their uses in medicine
06/16/2010EP2194787A1 Vegfr inhibitors containing a zinc binding moiety
06/16/2010EP2035379B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/16/2010EP1966167B1 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof
06/16/2010EP1756085B1 Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010CN1829711B Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders, process for their preparation and pharmaceutical compositions containing them
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN1764650B 2, 3, 6-trisubstituted-4-pyrimidone derivatives
06/16/2010CN101743240A ((phenyl)imidazolyl)methylheteroaryl compounds
06/16/2010CN101743239A cyanoisoquinoline
06/16/2010CN101743238A 3-(imidazolyl)-pyrazolo[3,4-b]pyridines
06/16/2010CN101743237A condensed anthranilamide insecticides
06/16/2010CN101743234A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
06/16/2010CN101743229A quinazolinamide derivatives
06/16/2010CN101743224A 7-substituted indole mcl-1 inhibitors
06/16/2010CN101743223A Novel compounds as cannabinoid receptor ligands
06/16/2010CN101735218A Piperidine carbamic acid ester derivative and application thereof
06/16/2010CN101735200A Quinazoline compound
06/16/2010CN101735199A o-formamidebenzoyl-pyrazole compound as well as preparation method and application thereof
06/16/2010CN101735198A Novel method for preparing c-Met inhibitor PF22341066
06/16/2010CN101735197A Method for synthesizing Imatinib
06/16/2010CN101735196A Method for synthesizing Imatinib
06/16/2010CN101735140A Chiral amino compound, method for synthesizing same and application of anti-flu medicament tamifiu intermediate thereof
06/16/2010CN101260122B 2-(6'-iminopyridyl)quinoxaline metal complex compound and its preparing method and application
06/16/2010CN101099286B Method and installation means for installing an electrical machine
06/15/2010US7737627 OLED/organic light emitters using a compound of 9,9-dimethylfluorenes anda ring such as carbazole for electrical stabity; glass transition temperature; crystal growth inhibiters; low voltage; current density; industrial scale; charge transfer/generating compounds; color dopes
06/15/2010US7737285 [3-(4-{2-butyl-1-[4-(4chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl-amine, used as modulators of the interaction between the receptor for advanced glycated end products and its ligands; inflammation, nephropathy, atherosclerosis, retinopathy, Alzheimer's disease, erectile dysfunction
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/15/2010US7737282 amorphous compound of lansoprazole; antiulcer agent
06/15/2010US7737275 simple and low cost chemical process of 2-chloro-5-[3,6-dihydro-2,6-dioxo-4-(trifluoromethyl)-1(2H)-pyrimidinyl]-4-fluoro-N-[[methyl(1-methylethyl)amino]sulfonyl]benzamide
06/15/2010US7737171 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737170 Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIS
06/15/2010US7737163 Benzimidazolone carboxylic acid derivatives
06/15/2010US7737153 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
06/15/2010US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds
06/15/2010US7737148 Hydroxyiminopiperazines administered to animals as analgesics; inhibitors of vanilloid receptors
06/15/2010US7737143 such as 6-(1H-Benzimidazol-1-yl)-N-benzylpyrazin-2-amine, used as antidiabetic, anticarcinogenic and antiarthritic agents or for treating autoimmune diseases
06/15/2010US7737142 (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists
06/15/2010CA2555800C Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
06/15/2010CA2495577C Novel benzoimidazole derivatives useful as antiproliferative agents
06/15/2010CA2442256C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
06/15/2010CA2440648C Imidazolidine derivatives, their preparation, and their use as antinflamatory agent
06/15/2010CA2430518C Guanidine and amidine derivatives as factor xa inhibitors
06/15/2010CA2328440C Heterocyclically substituted amides used as calpain inhibitors
06/10/2010WO2010065802A2 Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
06/10/2010WO2010065801A1 Amine substituted piperazine melanocortin receptor-specific compounds
06/10/2010WO2010065800A1 Hydrazine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065799A2 Amine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010065743A2 Bicyclic compounds and methods of making and using same
06/10/2010WO2010065717A1 Morpholinone compounds as factor ixa inhibitors
06/10/2010WO2010065704A1 Method for preparing a spiroindoline and a precursor thereof
06/10/2010WO2010065110A2 Antimicrobials
06/10/2010WO2010064735A1 Quinolone compound and pharmaceutical composition
06/10/2010WO2010064701A1 Pharmaceutical agent comprising quinolone compound
06/10/2010WO2010064688A1 Pyrimidine derivatives, horticultural insecticides comprising said derivatives and method of use thereof
06/10/2010WO2010064627A1 1,3,5-triazine derivative, process for producing same, and organic electroluminescent element comprising same
06/10/2010WO2010064597A1 Piperidine derivative
06/10/2010WO2010064300A1 Composition for treatment of esophageal cancer
06/10/2010WO2010063996A2 Antibacterial compounds
06/10/2010WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/10/2010WO2010063724A1 Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
1 ... 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 ... 1080